Literature DB >> 10903230

Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome.

M Ruiz1, A Torres, S Ewig, M A Marcos, A Alcón, R Lledó, M A Asenjo, A Maldonaldo.   

Abstract

Noninvasive and invasive diagnostic techniques have been shown to achieve comparable performances in the evaluation of suspected ventilator-associated pneumonia (VAP). We studied the impact of both approaches on outcome in a prospective, open, and randomized study in three intensive care units (ICUs) of a 1,000-bed tertiary care university hospital. Patients with suspected VAP were randomly assigned to noninvasive (Group 1) versus invasive (Group 2) investigation (tracheobronchial aspirates [TBAS] versus bronchoscopically retrieved protected specimen brush [PSB] and bronchoalveolar lavage [BAL]. Samples were cultured quantitatively, and BAL fluid (BALF) was examined for intracellular organisms (ICO) additionally. Initial empiric antimicrobial treatment was administered following the guidelines of the American Thoracic Society (ATS) and adjusted according to culture results (and ICO counts in Group 2). Outcome variables included length of ICU stay and mechanical ventilation as well as mortality. Overall, 76 patients (39 noninvasive, 37 invasive) were investigated. VAP was microbiologically confirmed in 23 of 39 (59%) and 23 of 37 (62%) (p = 0.78). There were no differences with regard to the frequencies of community-acquired and potentially drug-resistant microorganisms (PDRM). Antimicrobial treatment was changed in seven patients (18%) of Group 1 and 10 patients (27%) of Group 2 because of etiologic findings (including five of 17 with ICO = 2% (p = not significant [NS]). Length of ICU stay and mechanical ventilation were also not significantly different in both groups. Crude 30-d mortality was 31 of 76 (41%), and 18 of 39 (46%) in Group 1 and 14 of 37 (38%) in Group 2 (p = 0.46). Adjusted mortality was 16% versus 11% (p = 0.53), and mortality of microbiologically confirmed pneumonia 10 of 23 (44%) in both groups (p = 1.0). We conclude that the outcome of VAP was not influenced by the techniques used for microbial investigation.

Entities:  

Mesh:

Year:  2000        PMID: 10903230     DOI: 10.1164/ajrccm.162.1.9907090

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  63 in total

Review 1.  Diagnosis of pneumonia and monitoring of infection eradication.

Authors:  M Ruiz; C Arosio; P Salman; T T Bauer; A Torres
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

Review 2.  The pulmonary physician in critical care 1: pulmonary investigations for acute respiratory failure.

Authors:  J Dakin; M Griffiths
Journal:  Thorax       Date:  2002-01       Impact factor: 9.139

3.  Approaches to suspected ventilator-associated pneumonia: relying on our own bias.

Authors:  S Ewig; A Torres
Journal:  Intensive Care Med       Date:  2001-04       Impact factor: 17.440

4.  Outcome of postoperative pneumonia in the Eole study.

Authors:  Hervé Dupont; Philippe Montravers; Rémy Gauzit; Benoît Veber; Jean-Louis Pouriat; Claude Martin
Journal:  Intensive Care Med       Date:  2003-01-14       Impact factor: 17.440

Review 5.  All great truths are iconoclastic: selective decontamination of the digestive tract moves from heresy to level 1 truth.

Authors:  Hendrick K F van Saene; Andy J Petros; Graham Ramsay; Derrick Baxby
Journal:  Intensive Care Med       Date:  2003-04-10       Impact factor: 17.440

6.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

7.  Ventilator-associated pneumonia: diagnosis, treatment, and prevention.

Authors:  Steven M Koenig; Jonathon D Truwit
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

8.  Diagnosis of ventilator-acquired Pneumonia: Where Do We Go From Here?

Authors:  B Lynn Johnston; John M Conly
Journal:  Can J Infect Dis       Date:  2003-03

Review 9.  [Ventilator-associated pneumonia].

Authors:  R Dembinski; R Rossaint
Journal:  Anaesthesist       Date:  2008-08       Impact factor: 1.041

10.  A Bayesian decision-support system for diagnosing ventilator-associated pneumonia.

Authors:  Carolina A M Schurink; Stefan Visscher; Peter J F Lucas; Henk J van Leeuwen; Erik Buskens; Reinier G Hoff; Andy I M Hoepelman; Marc J M Bonten
Journal:  Intensive Care Med       Date:  2007-06-16       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.